Projects and Funders

Prevention, Care and Treatment (PCT) Projects

Project CodeProgram Name/DetailsPartners (Funder/Other Partners)Status
001BAnnual subvention from the Government of Uganda (GOU) through Makerere University to bridge the funding gap in the IDI's Adult Infectious Diseases ClinicGovernment of Uganda/Makerere UniversityOngoing (annual renewal)
021BSkin biopsies for patients suspected to have karposis sarcomaUniversity of California, San Francisco (UCSF)Completed
046Project for enhancing livelihoods of IDI Clinic patientsDonald & Jennifer Holzworth and the Triangle Community Foundation/Accordia Global Health FoundationCompleted
049Preventing HIV transmission by HIV positive adolescents and amongst discordant couples (Phases 1 and 2)The Uganda Civil Society Basket Fund (a range of funders including USAID, DFID, DANIDA and Irish Aid)Completed
056Scaling-up an urban-setting family planning & HIV services integrated service delivery model in Kampala, UgandaTides FoundationCompleted
062Adolescent Transition Clinic and Peer Support Program at the AIDC for provision of adolescent-specific HIV prevention, care and treatment servicesPoenki vzw – Positief, BelgiumCompleted
092CSF – Strengthening HIV Care and Treatment in Regional Referral Hospitals in Uganda (Phases 1, 2 and 3)The Uganda Civil Society Basket Fund (a range of funders including USAID, DFID, DANIDA and Irish Aid)Completed
110The IDI Young Adult Patients' Scholarship ProgramMr. Don Holzworth/Accordia Global Health FoundationOngoing
134Sustaining public HIV services in a post - PEPFAR world through socially acceptable charging of patientsGrand Challenges Canada (GCC)/Dalhousie UniversityCompleted
159Implementation of TAMA (Treatment Advise by Mobile Alerts): the open source m-health component of the Call for Life Academy – a dynamic virtual communityJanssen Pharmaceuticals Global Public Health R&DCompleted
170AThe Secretariat: this is a component of the Ugandan Academy for Health Innovation and Impact which is a flagship implementation of the Janssen Connect for LifeTM program. The Secretariat will provide strategic oversight to ensure that the objectives of the Ugandan Academy are accomplished. The primary objectives of the Academy include: 1. To gain an understanding on conditions affecting HIV and TB drug treatment effectiveness and prevention of HIV and TB drug resistance in Uganda; 2. to develop and implement models to facilitate the professional development of Health Care Professionals and Allied Health Care workers as well as to promote health knowledge, healthy behaviors and adherence to treatment through the use of mobile health (m-health) services and other trending technologies.Janssen Global Public Health R&DOngoing
170BGovernance support for Connect for LifeJanssen Global Public Health R&DOngoing
170CMhealth/Call for Life: Is a mhealth demonstration project also known as “Call for Life” which aims to support people living with HIV with medication adherence and management of their symptoms. The call for Life program was developed by Janssen as part of its commitment to global public health and in collaboration with their partners and is a voice or text based interaction using simple mobile phones.Janssen Global Public Health R&DOngoing
170DCapacity Building: This project is aimed at enhancing the competence of health workers to manage HIV, TB, and other infectious diseases. IDI will provide educational opportunities to health workers and increase access to educational resources and subject matter experts through electronic media.Janssen Global Public Health R&DOngoing
170ELong term longitudinal cohort study; is a 10 year ART cohort being undertaken at IDI, which will study the long term effects of ART, as well as long term adherence and management of second and third line treatments. 1000 patients have already been enrolled in this research trial, and it will monitor viral load and CD4 counts as well as markers of non-communicable diseases (NCD) such as hypertension, diabetes and high cholesterol.Janssen Global Public Health R&DOngoing
170FMasters/PHD Students; The Ugandan Academy for Health Impact and Innovation’s goal is to undertake clinical, research and training programmes relevant to the health needs and problems of Uganda. It aims at awarding scholarships to Masters in Public Health, Post-Doctoral and PHDs annually.Janssen Global Public Health R&DOngoing
170GSub awardsJanssen Global Public Health R&DOngoing
170HJanssen Global Health Fellows; Janssen staff with specific skills will be encouraged to undertake a 3 month to 12 months assignment within the Call for Life Academy to support specific projects or the secretariat in order to further understand the impact of the Call for Life Academy and novel ways to sustain these services.Janssen Global Public Health R&DOngoing
181   
181B   
185Global Health Security Partner Engagement: Expanding Efforts and Strategies to Protect and Improve Health Globally. Building Ugandan national capacity for management of Emerging Infectious Diseases (EID) with emphasis on Biosafety and Biosecurity capacity, Antimicrobial Resistance (AMR) Prevention and National Laboratory Systems Strengthening.Centers for Disease Control and Prevention (CDC)Ongoing
191AEnhancing capacity for Phase I Ebola Virus Disease (EVD) clinical trials in Uganda: A project to enhance capacity for the conduct of Phase 1 clinical trials of therapeutic agents in an academic clinical trial unit in Kampala, Uganda.European & Developing Countries Clinical Trials Partnership (EDCTP) (Co-funding)Ongoing
191BEnhancing capacity for Phase 1 Ebola Virus Disease (EVD) clinical trials in Uganda: A project to enhance capacity for the conduct of Phase 1 clinical trials of therapeutic agents in an academic clinical trial unit in Kampala, Uganda.World Health Organisation TDR (WHO) (Co-funding)Ongoing
205A

Evaluation of the pharmacokinetics and safety of etonogestrel when co‐administered with darunavir‐based or rilpivirine based antiretroviral therapy among HIV positive Ugandan women

Janssen Pharmaceutica NV Ongoing
205BEvaluation of the pharmacokinetics and safety of levonorgestrel when co‐administered with darunavir‐based antiretroviral therapy among HIV positive Ugandan womenJanssen Pharmaceutica NVOngoing 
207The Joint Mobile Disease Intervention Clinical Capability (JMEDICC) in Uganda(Start-up phase of JMEDICC and sepsis clinical research in Uganda (Fort portal). The project aims to provide a platform of advanced supportive care, scientific rigor, logistical capacity, and flexibility that will enable critical clinical trials during future filovirus outbreaks providing a mechanism to accelerate the development of appropriate medical countermeasures (MCM).US Naval Medical Research Centre(NMRC) in partnership with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Department of Defence(DoD) through Makerere University Water Reed Project(MUWRP)Ongoing

Training Projects

Project CodeProgram Name/DetailsPartners (Funder/Other Partners)Status
005BJoint Uganda Malaria Training Program (JUMP)Exxon Mobil /Accordia Global Health FoundationCompleted
005ETechnical assistance to Malawi's malaria control unitExxon Mobil / Accordia Global Health Foundation (Accordia)Completed
019HIV/AIDS Training for African armed forces (medical officers, nurses, pharmacy workers and lab workers): Contracts in 2005/2006,2007/2008,2008/2009 and 2010/2011US Department of Defense (DOD)/ Accordia Global Health Foundation (Accordia)Completed (contracts)
019BDepartment of Defence-UN Peace keeper trainingUS Department of Defense (DOD) via Accordia Global Health Foundation (Accordia)Completed
019CPiloting of IDI's Laboratory Training in French Speaking Africa (Mali)US Department of Defense (DOD) via Accordia Global Health Foundation (Accordia)Completed
019DDistance Learning for medical workers in ZambiaUS Department of Defense (DOD) via Accordia Global Health Foundation (Accordia)Completed
020Developing Centres of Excellence in Laboratory trainingBecton Dickinson through the Accordia Global Health Foundation (Accordia)Completed
028Support to the HIV/AIDS Training Program/Training of Medical ProfessionalsPRANA – Stiftung/Accordia Global Health Foundation (Accordia)Completed
037Building the Capacity of Ugandan people Defence Forces (UPDF) Pharmacy Workers to provide quality anti-retroviral careGovernment of Ireland/Irish Aid through the Embassy of IrelandCompleted
040Contract for IDI to conduct a series of Malaria Management Training coursesPresidential Malaria Initiative (PMI)/US Centers for Disease Control and Prevention (CDC)Completed
N/ACapacity Building for the AIDS Treatment Information Centre (ATIC)The Civil Society Fund of the Government of Ireland/Realta Global AIDS FoundationCompleted
055HIV/AIDS Laboratory Service Training ProgramBecton Dickinson (BD)/PEPFAR/Accordia Global Health FoundationCompleted
061Support to the Uganda Stop Malaria ProjectUS Agency for International Development(USAID)/Johns Hopkins University (JHU) Center for Communications Programs(CCP)Completed
089Training in use of rapid diagnostic tests(RDTs) for malaria in fever management for the ACT PRIME study being conducted under IDRCInfectious Disease Research CollaborationCompleted
097Multidisciplinary training and on-site supervision for standardized TB case finding, diagnosis and care in rural treatment centers in UgandaWorld Health Organization/Stop TB Partnership (TB REACH)Completed
100BD PEPFAR IDI Lab Strengthening programBecton Dickinson (BD)/PEPFAR/Accordia Global Health FoundationCompleted
101Supporting STAR-South West’s Mentorship Training NeedsUnited States Agency for International Development (USAID) /Elizabeth Glazer Pediatric AIDS Foundation (EGPAF)Completed
113Piloting a comprehensive HIV prevention course for policy makers and senior programme managersRegional Aids Training Network (RATN)Completed
113BProject to Support The delivery of Advanced TB/HIV Co-Management for health care workersRegional Aids Training Network (RATN)Completed
113COnline Data Management Training ProgramRegional Aids Training Network (RATN)/MildmayCompleted
113DImproving HIV/AIDS Home Based Care through Training Community Nurses in Diagnosis and Management of Opportunistic InfectionsRegional Aids Training Network (RATN)/TASOCompleted
116Baylor-IDI in service training of health workers in Provider Initiated Counseling and Testing (PICT) for the SAINTS projectUS Centers for Disease Control and Prevention(CDC)/Baylor UgandaCompleted
136Training support to the USAID/Uganda Private Health Support ProgramUSAID /Cardno Emerging MarketsOngoing
138USAMRIID Capacity building programme/Infectious Diseases (Especially Dangerous Pathogens (EDP)) Training for East African physiciansU.S. Army Medical Research Institute of Infectious Diseases(USAMRIID)Ongoing
163 Establishing Pathways for Scale up of Low Dose High Frequency training in Uganda JHPIEGO Completed
164 Ebola curriculum development for West AfricaAccordia Global Health Foundation Completed
200Uganda Malaria Action Program for Districts;The aim of this project is to implement USAID-funded interventions to control and prevent malaria morbidity and mortality, and thereby minimize the social effects and economic losses and contribute to the reduction of under-five all-cause mortality rate, as a result of reduced malaria mortality. U.S Agency for International Development (USAID) / Malaria ConsortiumOngoing

Research Projects

                            

    

188A study to assess TB treatment outcomes in the HIV/TB co-infected patients receiving care and compare rural and urban settings and also identify factors associated with TB treatment outcome.European & Developing Countries Clinical Trials Partnership (EDCTP)/London School of Hygiene and Tropical MedicineOngoing

Project CodeProgram Name/DetailsPartners (Funder/Other Partners)Status
001APrevention in the Era of ARVsBill and Melinda Gates Foundation/Academic Alliance for HIV/AIDS Care and Prevention/Makerere UniversityCompleted
002The Kampala based Multi-Center International Trial to measure the efficacy of twice daily acyclovir suppressive therapy in preventing HIV transmission among heterosexual HIV discordant couples in which HIV- infected partner is HSV-2 seropositive and has a CD4 count of at least 250/mm3.Bill and Melinda Gates Foundation/University of WashingtonCompleted
002BProject to support additional research at the Kampala site of a Multi- Center International Trial to obtain and store blood and mucosal specimens in African HIV-1 discordant couples at key points for future validation of correlates identified in SIV macaque model.Bill and Melinda Gates Foundation/University of WashingtonCompleted
002CProject to support additional research at the Kampala site of a Multi- Center International Trial to measure the safety and efficacy of antiretroviral therapy in preventing HIV-1 acquisition among heterosexual HIV discordant couples in which the HIV infected partner has a CD4 cell count of at least 250/mm3 and does not otherwise meet the National guidelines for initiation of antiretroviral therapy.Bill and Melinda Gates Foundation/University of WashingtonCompleted
002DProject to support the Jinja site of a Multi-Center International Trial to measure the safety and efficacy of antiretroviral therapy in preventing HIV-1 acquisition among heterosexual HIV discordant couples in which the HIV infected partner has a CD4 cell count of at least 250/mm3 and does not otherwise meet the National guidelines for initiation of antiretroviral therapy.Bill and Melinda Gates Foundation/University of WashingtonOngoing
002EProject to support additional research at the Kampala site of a Multi- Center International Trial to measure the safety and efficacy of antiretroviral therapy in preventing HIV-1 acquisition among heterosexual HIV discordant couples Objective Measures and Intervention for Adherence in an HIV Prevention TrialBill and Melinda Gates Foundation/University of WashingtonCompleted
002FThe Jinja based Multi-Center International Trial to measure the efficacy of twice daily acyclovir suppressive therapy in preventing HIV transmission among heterosexual HIV discordant couples in which HIV- infected partner is HSV-2 seropositive and has a CD4 count of at least 250/mm3Bill and Melinda Gates Foundation/University of WashingtonCompleted
002GValidation of Daktari Diagnostic’s Portable Instrument for Point –of- Care CD4 TestingBill and Melinda Gates Foundation/Daktari Diagnostics, Santa Clara, California/University of WashingtonCompleted
002JThe partners ARV Based HIV Prevention in couples study, a study to optimize targeted delivery and sustained use of ARV based HIV-1 prevention in African HIV-1 serodiscordant couplesBill and Melinda Gates Foundation/University of WashingtonCompleted
003Tibotec's TMC 278 multi-site phase II dose-finding drug trialTibotec Pharmaceuticals (a Johnson & Johnson subsidiary)Completed
006Validation of algorithm for monitoring the virological efficacy of ART in AfricaSAIC-Frederick, Inc. (SAIC)Completed
007Establishment of Pharmacokinetic Laboratory Capacity at IDIDevelopment Co-operation Ireland (DCI)/Realta Global HIV/AIDS FoundationCompleted
008Standard Viral Load and genotype resistance testing using filter paper transferChelsea and Westminster Healthcare NHS TrustCompleted
009Unrestricted support to Phd. StudentAbott Laboratories (Belgium)/Institute of Tropical Medicine, AntwerpCompleted
010A series of research projects through the TARGETS (Team for Applied Research to Generate Effective Tools and Strategies for Communicable Disease Control) grantDepartment for International Development /London School of Hygiene and Tropical Medicine / Makerere University School of Public HealthCompleted
011Human Herpesvirus-8 Replication in a Hyper-Endemic Region”Fred Hutchinson Cancer Research Center, Early Detection Initiative (EDI)/University of WashingtonCompleted
011BHHV-8 Replication and Progression to Malignancy in AfricaDoris Duke Charitable Fund/University of WashingtonCompleted
013The Gilead Foundation/ Accordia Exchange Program in International Medicine (sponsor for the annual Sewankambo Scholarships Program)Gilead Foundation/The Accordia Global Health FoundationOngoing (Annual renewals)
017Immune Reconstitution Inflammatory Syndrome (IRIS) in Ugandan HIV- infected patients after initiation of potent anti-retroviral therapy: a pilot studyUS National Institutes of Health (NIH) /The Academic Health Center at the University of MinnesotaCompleted
018Developmenmt of a site office at IDI for the academic Collaboration between the Canadian HIV Trials Network (CTN) and IDI to pursue HIV/AIDS Clinical TrialsCanadian HIV Trials Network (CTN)Completed
018CResearch capacity Building through the Canada –Africa Prevention Trials (CAPT) Network,International Development Research Centre (IDRC) through Uganda Virus Research Institute (UVRI)Completed (Annual renewals)
020Evaluation of the pharmacokinetic interaction between the antimalarial Coartem (Artemether and Lumefantrine) and commonly prescribed antiretroviral drugs Nevirapine and Efavirenz and the antituberculous drug Rifampicin.Haughton Institute, St James’ Hospital, Dublin, IrelandCompleted
021Anti-retroviral therapy of AIDS-related Kaposis Sarcoma in AfricaNational Institutes of Health (NIH)/ University of California, San Francisco (UCSF)Completed
022Hepatitis B Virologic Response in HIV Co-infected patients on Treatment with Tenofovir Versus Lamivudine Containing Regimens: A Randomized Controlled Study”Gilead Sciences Inc.Completed
023Assessing sexual risk reduction needs among adolescents living with HIVPrivate (undisclosed) funder/Institute of Tropical Medicine, AntwerpCompleted
027Support to a Fellow to build pharmacokinetic capacity in IDIEuropean and Developing Countries' Clinical Trials Partnership (EDCTP)/ University of Cape TownCompleted
029Comparison of the steady state pharmacokinetics of nevirapine, stavudine plus lamivudine in HIV positive Ugandan patients taking Triomune with the pharmacokinetics of the originator productsDevelopment Co-operation Ireland /Realta Global AIDS FoundationCompleted
030Comparison of nevirapine levels with and without dose escalation in HIV- infected patients commencing antiretroviral therapy who are also receiving rifampicin based anti-tuberculosis therapy AND Lumefantrine Pharmacokinetics when administered as a fixed dose combination with artemether in HIV positive patients on KaletraUniversity of LiverpoolCompleted
031Co-funding support for the EDCTP-funded infant and adolescent TB Vaccine Site preparation study (IDI Project #039)Bill and Melinda Gates Foundation/AERAS Global TB Vaccine FoundationCompleted
033Comparison of the pharmacokinetics of antiretroviral agents in HIV infected Ugandan women during and after pregnancyDr. Ralph and Marian Falk Trust /Northwestern University, ChicagoCompleted
034Support to the Ugandan site of a multi-site cross sectional survey of HIV- 1 Viral Co-Receptor TropismPfizer Inc./PAREXEL International (Pty) Ltd (CRO)Completed
035Social and Behavioral HIV Research Capacity Building in Uganda”National Institutes of Health (NIH) /RAND Corporation of USACompleted
036Joint Uganda Malaria Program (JUMP) Auxiliary Study on Febrile Case Management with Rapid Diagnostic Tests (RDT)Exxon Mobil/Accordia Global Health FoundationCompleted
038Pathogenesis and Identification of predictive factors of TB Immune Reconstitution Inflammatory Syndrome (TB IRIS)”European Commission (EC) FP6/The Institute of Tropical Medicine (ITM) of Belgium (Coordinator), Infectious Diseases Institute (IDI) of Uganda, Université Libre de Bruxelles (ULB) of Belgium, Academic Medical Center (AMC) of the Netherlands, Vrij Universiteit Brussels-The Flanders Interuniversity Institute for Biotechnology (VUB) of Belgium and Institut Pasteur de Lille (IPL) of France.Completed
039Infant and adolescent TB Vaccine Trial sites preparation at the Makerere University School of Public Health Demographic Surveillance Site (DSS) in Iganga and Mayuge districts (including capacity building and Phd. support for research fellows)European and Developing Countries Clinical Trials Partnership (EDCTP) / Karolinska International Research & Training Committee, Sweden , Swedish Institute for Infectious Diseases Control,, Sweden, Institute of Tropical Medicine (ITM), Belgium , Institute of Medical Immunology (IMI), Belgium/Makerere UniversityCompleted
039CEDCTP 1 NCE : Support for Phd. Studies (from Capacity Building Component of project #039)European and Developing Countries Clinical Trials Partnership (EDCTP)Completed
041Minocycline in the Treatment of HIV-Associated Cognitive Impairment in UgandaUS National Institutes of Health (National Institute of Neurological Disorders and Stroke-NINDS) /Neurologic AIDS Research Consortium (NARC) of Washington University (WU), St. Louis, MissouriCompleted
042PEPFAR Palliative Care Public Health Evaluation in Kenya and UgandaUnited States Agency for International Development (USAID)/University of North Carolina/King's College London/African Palliative Care Association (APCA)Completed
043Project to achieve (Infectious Diseases Network for Treatment and Research in Africa (INTERACT) Program Objective III: “A strengthened capacity to conduct clinical trials of new drugs, prevention technologies and interventions for HIV/AIDS, tuberculosis and malaria in accordance with international strategies, at 2 clinical trial sites in Rwanda and Uganda selected by EDCTP/NACCAPEuropean Commission(Europe Aid)/Academic Medical Centre (AMC) of the University of Amsterdam/AMC’s Centre for Poverty- Related Communicable Diseases (CPCD)/Makerere University.Completed
044Support for the IDI site of the Delivery of Anti-Retroviral Therapy (DART) projectRockefeller Foundation/Medical Research Council (MRC)/Joint Clinical Research Centre (JCRC)Completed
045Grant to develop the capacity of the IDI to perform HIV clinical research and to diagnose opportunistic infections and malignanciesBelgian Government/Belgium Technical Cooperation’s VLIR (Interuniversity Cooperation) /University of Antwerp /Makerere UniversityCompleted
047Comparison of the Development of Thymidine Analogue Mutations with CD- 4 Monitoring Alone Versus CD4 Monitoring plus Viral Load Monitoring in Naïve HIV-1 individuals on Fist Line Antiretroviral Therapy in AfricaUS National Institutes of Health(NIH) /SAIC-Frederick,IncCompleted
048Adherence Monitoring Project (FHI)Adult Retention in anti-retroviral therapy in Tanzania, Uganda and ZambiaCenters for Diseases Control and Prevention (CDC)/Family Health International (FHI)Completed
052Evaluation of the pharmacokinetic interaction between the antimalarial Coartem (Artemether and Lumefantrine) ;and commonly prescribed antiretroviral drugs Nevirapine and Efavirenz and the antituberculous drug Rifampicin.Haughton Institute, St James’ Hospital, Dublin, IrelandCompleted
054Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis (COAT)National Institutes of Allergy and Infectious Diseases/ University of MinnesotaOngoing
057Integrated Infectious Disease Capacity Building Program (IDCAP)Bill and Melinda Gates Foundation/Accordia Global Health FoundationOngoing
059HIV Dementia and Sensory Neuropathy in UgandaNational Institute of Mental Health via John Hopkins UniversityCompleted
060Joint project to evaluate the performance of three LED-based systems for case detection of tuberculosisFoundation for Innovative New Diagnostics (FIND)Completed
063Project to support IDI's participation in the International Epidemiologic databases to Evaluate AIDS in East Africa (IeDEA)National Institutes of Health via Indiana UniversityCompleted
064Study on Peri-operative Exposure to Blood and Body Fluids: Incidence, Causes and Attitudes in UgandaNIH-National Institute of Allergy and Infectious Diseases/University of California San Francisco (UCSF)Completed
065Support to the Makerere University-Johns Hopkins University (MUJHU)Collaboration project: "A Multicenter Phase II trial of new TB vaccine in African Infants"European and Developing Countries Clinical Trials Partnership (EDCTP)/University of Cape Town (UCT)( Project Coordinator) / Makerere University-Johns Hopkins University (MUJHU)CollaborationCompleted
066Administrative and research support for the preparation and research of Fogarty International Clinical ScholarsUS National Institutes of Health (NIH) / Vanderbilt University Medical CenterOngoing (Annual renewals)
067Evaluation of the accuracy of the new CLONDIAG Pint of Care (POC) CD4 MachineCLONDIAG GmbH, a wholly-owned subsidiary of Inverness Medical Innovations Inc., GermanyCompleted
067BTesting the accuracy of the Pima CD4 MachineAlere Technologies Gmbh a wholly- owned subsidiary of ALERE Inc.Completed
068The Eastern and Southern Africa Research Network for Evaluation of Second line Therapy in HIV Infection (EARNEST) TrialEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Ongoing
071Research program to improve understanding and management of HIV and hepatitis B (HBV) co-infectionSAIC-FREDERICK, INC. a wholly owned subsidiary of Science Applications International Cooperation (SAIC) , USACompleted
072Impact of the use of a speaking book to help illiterate people to understand what it means to be a part of a clinical trialPfizer Inc.Completed
073Study on the added value of palliative care in the ART eraPrincess Diana Fund / African Palliative Care Association(APCA)Completed
074World Health Organization (WHO) District Clinician Manual EvaluationWorld Health OrganizationCompleted
076Multivitamins and AIDS ProgressionNational Institute of Health through Harvard School of Public HealthCompleted
078Global Health Research -Evaluation of pharmacokinetics of antiretroviral agents with and without food in HIV infected Ugandan adultsHaughton Institute, St. James’ Hospital, Dublin, IrelandCompleted
079Support for the IDI site of the Tuberculosis Clinical Diagnostics Research Consortium (TB-CDRC)US National Institutes of Health/ Johns Hopkins UniversityOngoing (Annual renewals)
080Use of SMS services to improve TB treatment completion in integrated Tuberculosis and HIV Care in Resource-Limited settingsMicrosoft Research Limited (MRL)Completed
082Immunopathogenesis of HIV-related Immune Reconstitution Inflammatory SyndromeNational Institutes of Health/ University of MinnesotaCompleted
084Impact of HIV and HIV therapy on Etiology & Outcome of meningitis in Uganda (NOAT)National Institutes of Health/ University of MinnesotaOngoing (Annual renewals)
087Uganda-UCSF Research Training Program in HIV Associated Malignancies (Project for early detection of Kaposi's sarcoma using community based health care providers in rural Uganda)National Institutes of Health (NIH)Completed (Annual renewals)
088Evaluation of Peri-Antiretroviral Fluconazole intervention among Cryptococcal Antigen positive (CRAG) HIV-infected patients in Sub Saharan Africa.Pfizer Inc.Completed
093EDCTP Research Fellowship ( William Worodria) Short and long term clinical and immunological outcomes of patients with HIV/TB co-infections on ART.European and Developing Countries Clinical Trials Partnership (EDCTP)Completed
093BEDCTP Senior Research Fellowship (Pauline Byakika) - Comparison of Efficacy and pharmacokinetics of Intravenous Artesunate vs. Intravenous Quinine for Treatment of Severe MalariaEuropean and Developing Countries Clinical Trials Partnership (EDCTP)- EEIGCompleted
093DEarly Childhood Transmission of Viral Hepatitis B among HIV and non- HIV infected mothers attending postnatal and immunization clinic in Gulu Hospital, Northern Uganda.European and Developing Countries Clinical Trials Partnership (EDCTP)Completed
093EEvaluating pharmacokinetic interactions between Artemisinin-based therapies and rifampicin-based tuberculosis treatment in African patients by Senior Fellowship - Dr MohammedEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Completed
095East African Consortium for Clinical Research - TB NODE (Upgrading of Lacor Hospital)The European Developing Countries Clinical Trials Partnership (EDCTP)/EACCR.Completed
098Evaluation of the impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains (QUINACT)European and Developing Countries Clinical Trials Partnership (EDCTP)/ Institute of Tropical Medicine (ITM) , AntwerpCompleted
099Optimizing Clinical Care Strategies and Laboratory Monitoring for Cost- effective Roll-Out of Antiretroviral Therapy in Africa (Lablite)The Medical Research Council/African Dialogue on AIDS Care (ADAC)Completed
102MamaMiso: A pilot study of Self-Administered Misoprostol to Prevent Bleeding after Childbirth in the communityBill and Melinda Gates Foundation/Gynuity Health Projects LLC/University of LiverpoolCompleted
104Monitoring and Evaluation of AIDS Treatment Information Center Project in order to expand services of the AIDS Treatment Information Center (ATIC) to Northern UgandaRealta Global AIDS FoundationCompleted
105Molecular Characterization of Mycobacterium Strains and Their Correlation to Clinical InformationMichigan State UniversityCompleted
107Validation of affordable saliva-based nevirapine test in Uganda. (saliva study)National Institutes of Health (NIH) through Joint Clinical Research Center(JCRC).Completed
109Measuring the impact of onsite mentorship on midlevel practitioners HIV and TB care and Treatment competencesUS Centers for Disease Control and Prevention (CDC)Ongoing (Annual renewals)
111Operational Research for Cryptococcal Antigen screening to improve ART survivalCenters for Disease Control and PreventionOngoing (Annual renewals)
111Evaluation of peri-antiretroviral Fluconazole Intervention among crptococcal antigen positive (CRAG) HIV-infected patients in sub- saharan Africa.Pfizer Inc.Completed
112Ancillary study of Genital Mucosal Sampling among female participants in the Partners PrEP studyNational Institutes of Health/University of WashingtonCompleted
114Research on Mechanisms for CD4 T-Cell Death among HIV –Infected HAART –Treated African Adults Displaying poor CD4 T -Cell Reconstitution Despite effective viral suppressionUniversity of California / Centers for Aids Research (CFAR)Completed
114BStudy on The role of regulatory T cells in suboptimal CD4 recovery in HAART –Treated African cohort. (Glocal Fellowship)University of California Global Health Institute (UCGHI)Completed
114CGlocal Fellowship - Dr. Semeere AggreyUniversity of California Global Health Institute (UCGHI)Completed
114DGlocal Fellowship - Isabella EpiuUniversity of California Global Health Institute (UCGHI)Completed
115D4T Study: ‘A Randomized, Double Blind, Multi Centre, Parallel Group Phase III Study to Demonstrate Non inferiority of Stavudine (d4T; 20mg BID) Compared with Tenofovir Disoproxil Fumarate (TDF; 300 mg QD) When Administered in Combination with Lamivudine (3TC) and Efavirenz (EFV) in Antiretroviral Naive Patients Infected with HIV-1’Bill and Melinda Gates Foundation/Wits Reproductive Health & HIV Institute/Pharmaceutical Product Development South Africa (Pty) Ltd (PPD)Completed
117Project for Infection and immunity Research Training to implement the applied clinical research & evidence based medicine (ACREM) and good clinical practice (GCP) in UgandaLondon School of Hygiene and tropical MedicineCompleted
118Research on Point-of-Care Technologies (POC) for Sexually Transmitted Diseases (STDs)National Institutes of Health/Johns Hopkins University Center for Point- of-Care (POC) Technologies Research.Ongoing
119Study on Outcome related Tuberculosis-HIV drug-concentration in Uganda (SOUTH)University of ZurichOngoing
119B Intensive Pharmacokinetic analysis of anti-TB drugs in TB/HIV co-infected adults in Uganda.Study on the outcomes related to Tuberculosis and HIV drug concentrations in UgandaUniversity of ZurichOngoing
123Study on the Effect of Food on the Steady –State Pharmacokinetics of Rilpivirine when administered as a fixed Dose Combination in Ugandan Adults Janssen Pharmaceutical NV TurnhoutsewegCompleted
124Prospective case-control study of Immune Responses in HIV-infected patients with and without TB - Case AIDs Clinical Trials UnitNational Institutes of Health (NIH) through Case Western Reserve University (CWRU)Completed
126The open-labelled, pilot demonstration and evaluation project of antiretroviral-based HIV-1 prevention among high-risk HIV-1 serodiscordant African couples (Partner's Demonstration project)USAID/ University of WashingtonOngoing
128CFAR-Expanding UW Malaria Epidemiology Immunology Research in Kampala.USAID/University of WashingtonCompleted
130A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapyNational Institute of Child Health & Human Development (NIH)/North Western UniversityCompleted
130BPharmacologic strategies to use the levonorgestrel implant in HIV infected women; Pharmacokinetic evaluation of increased dose levonorgestrel implant and efavirenz-based antiretroviral therapy in hiv-infected ugandan womenNational Institute of Health (NIH) / University of NebraskaOngoing
131Study on Alcohol consumption and Alcohol reduction intervention among HIV infected persons in a large urban HIV clinic in Uganda.Wellcome Trust/Makerere University (Phd. Project support through the THRIVE mechanism)Ongoing
132SALIF-Switching at low HIV-1 RNA to Fixed Dose CombinationsJassen-Cilag InternationalCompleted
133Study on the antifungal therapeutic effects of Sertraline in HIV-infected adults with Cryptococcal meningitisGrand Challenges CanadaCompleted
135Improving drug adherence among adolescents in Uganda using SMS RemindersNational Institutes of Health (NIH) / RAND Corporation, USAOngoing
137Study to evaluate the accuracy and optimal use of the Eiken TB LAMP test for TB diagnosis in an HIV-prevalent setting in Uganda.Foundation for Innovative New Diagnostics (FIND)Completed
140Nutrition and Treatment Outcome: Development of a Ugandan – Irish HIV/ Nutrition Research Cluster (NOURISH)Irish Aid/Trinity College Dublin (TCD)Ongoing
141PISE-Partnering in Science EngagementWellcome TrustCompleted
142Optimizing Delivery of ART/PrEP for HIV Prevention through Qualitative researchNational Institutes of Health/Harvard UniversityOngoing
143Currier Project - Support to IDI to create capcity for running a blood culturing serviceJohns Hopkins UniversityCompleted
145Innovative demand creation for voluntary Medical Male CircumcisionBill and Melinda Gates Foundation/International Initiative for Impact Evaluation (3ie)Completed
147Real World PrEP Adherence in serodiscordant African couplesUS National Institutes of Health/Massachusetts General HospitalOngoing
148Doris Duke International FellowsDoris Duke Charitable FoundationCompleted
N/ATrial site for conducting evaluations of point of care (POC) assay performance: POC CD4 testsUNITAID/ London School of Hygiene and Tropical MedicineOngoing
149Development and validation of an assay for quantitation of antiretroviral in human breast milkUniversity of LiverpoolCompleted
150C Rapid Diagnosis of Trichomonas Vaginalis in Women Attending a Sexually Transmitted Disease Clinic in Uganda; This study aims to evaluate the loop mediated isothermal amplification assay for the rapid diagnosis of trichomonas vaginalis in women attending a sexually transmitted disease clinic in Uganda National Institutes of Health(NIH) / University of California San Francisco  Ongoing 
151AVAC -HIV Prevention Research Advocacy Fellowship (Charles Brown)AIDS Vaccine Advocacy Coalition(AVAC)Completed
155Pharmokinetic Evaluation of Etonogestrel Implant and Non-Nucleoside Reverse Transcriptase Inhibitor based Antiretroviral Therapy in HIV Infected Ugandan WomenThe Society of Family Planning Research Fund through Magee-Women’s Research Institute & Foundation (MWRIF)Completed
156Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D43): Building research capacity for HIV Co-infection in Uganda: TB,Crypotococcus and Viral HepatitisNIH thru Johns Hopkins UniversityOngoing
157PrEP and Breast Feeding StudyBill & Melinda Gates via University of WashingtonCompleted
160 Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates(Dolphin): A Pilot Study Viiv Health Care / University of Liverpool Ongoing
160BIntegrase interactions with Artemesinin-Cont Therapies:DoIACT : Viiv Health Care / University of Liverpool Ongoing 
161 HIV and Hepatocellular carcinoma (HCC) in Uganda (H2U): Study to define HCC risk; contrast etiology of HIV- associated vs. non-HIV associated HCC ; and characterize pathways of HIV-accelerated hepatocarcinogenesis  while building the related research infrastructure National Institutes of Health(NIH) / Johns Hopkins UniversityOngoing 
162 Estimation of prevalence of Aspergillus hypersensitivity in HIV patients post PTB treatment attending the Infectious Diseases Institute (IDI) clinic in Kampala, Uganda (Research fellowship award for Richard Kwizera) International Society for Infectious Diseases (ISID)Ongoing 
165 Impact of neonatal exposure to malaria and HIV on the frequency, phenotype and function of YQ T cell subsets at birth (Research Fellowship award for Frederick Lutwama) National Institutes of Health(NIH) / University of California Completed 
167 Impact of nutrition on immunity and pharmacokinetics in HIV infected malnourished Ugandan children (Research Fellowship award for Judy Orikiriza)Thrasher Research Fund Completed 
168Epidemiology of Cardiovascular Disease among Older-Age People Living with HIV on Antiretroviral Therapy.Massachusetts General Hospital, Boston, USA.Ongoing
169AThe Isha Grant to coordinate activity on behalf of MicroResearch in East Africa.MicroResearchOngoing
169BKT Pregnancy Study: Use of Knowledge Translation principles and exchange to disseminate results of newborn death audits to Luwero District Health TeamMicroResearchOngoing
169CPartograph projectMicroResearchOngoing
171The PrEP and Pregnancy Study is an open-label, study of pre-exposure prophylaxis by HIV uninfected women who choose to use (or not use) pre-exposure prophylaxis. The study is nested within the Partners Demonstration Project.The objective of this effort is to enroll and maintain a cohort women participating in the Partners Demonstration Project who become pregnant.University of WashingtonOngoing
173WoScaDep; A career development programme to support women scientists at Makerere University College of Health Sciences.World Health OrganisationCompleted
175To be a site for undertaking clinical performance studies for CD4 Point of care devices as and when they are available including Phase 1, Phase2, Phase 3 and Phase 4 studies.UNITAID/London School of Hygiene and Tropical medicineOngoing
176Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis (MRC -ASTROMedical Research CouncilOngoing
177RHINO: Comparing type and prevalence of HIV Drug resistance in treatment experienced and naïve HIV-infected adults in Uganda and SwazilandUniversity of ZurichCompleted
178UOL Fellowship for Ms.Kay Seden:Medical Research Council UK fellowship focusing on prevalence of, and harm caused by medication error in antiretroviral programs in Uganda.Medical Research Council / University of LiverpoolOngoing
179Wellcome Trust Fellowship awarded to Dr. Catriona Waitt to implement a project on Understanding the pharmacokinetics of antiretroviral drugs in breastfeeding mother-infant pairsWellcome trust/University of LiverpoolOngoing
180Project for Infection and immunity Research Training to implement the applied clinical research & evidence based medicine (ACREM) and good clinical practice (GCP) in UgandaWellcome Trust/London school of Hygiene and Tropical medicineOngoing
182A Promoting Early Diagnosis of Kaposi’s Sarcoma in Uganda;The project seeks to assess the magnitude and determinants of awareness of Kaposi’s Sarcoma (KS) among representative samples of HIV-infected adults, community level health advocates or providers and facility-based health providers.  The project also seeks to improve the awareness of KS through creation of KS-related educational materials for community residents and efficient models for training community-level health providers.National Institutes of Health(NIH) /University of California San Francisco  Ongoing
182BPrevention and Early Detection of Cervical Cancer through Self-Administered Screening in the Community;The overall goal of this project is to evaluate a community-based cervical cancer screening program while developing the local capacity for biomedical research.National Institutes of Health(NIH) / University of California San Francisco Ongoing
182CRapid Case Ascertainment (RCA) to evaluate Kaposi’s sarcoma;The project’s overarching objective is to better understand the “who, what, and why” regarding KS after initiation of ART and compare this to the KS that occurs prior to ARTNational Institutes of Health(NIH) / University of California San FranciscoOngoing
182DAdministrative/Coordinating Core : Monitor and evaluate progress of the consortium through assessment of interim process goals and major scientific milestones, monitor the progress of the career development, capacity building and research goals of the consortium. National Institutes of Health(NIH) / University of California San Francisco Ongoing 
182EMentoring Career Development Core: Mentor and provide protected time for three emerging Ugandan principal investigators working in the field of HIV-associated malignancies as they develop their academic and leadership portfolio and mature towards independenceNational Institutes of Health(NIH) / University of California San Francisco Ongoing
182FData Management and Biostatistical Analysis Core: The goal of this project is to provide expertise and a common platform for primary data collection and data management. The project also seeks to provide project-specific biostatistical support both during the planning of new research and during the analysis of ongoing studies and as well as specialized biostatistical instruction to emerging Ugandan principal investigators. National Institutes of Health(NIH) / University of California San Francisco Ongoing
184MSc in Medical Statistics for Patience Nyakato. Sample-based tracing of HIV-infected patients lost to follow-up from care before the initiation of antiretroviral therapy; The aim of this project is to correct estimates of retention among pre-ART patients in rural and urban Uganda using a sample based methodologyEuropean and Developing Countries Clinical Trials Partnership (EDCTP)/ London School of Hygiene and Tropical medicineOngoing
187Smartphone confocal microscopy for diagnosing Kaposis Sarcoma; The aim of the study is to evaluate the use of a confocal microscope mounted on a mobile device to detect KS in the skin.National Institutes of Health (NIH)/Massachusetts General Hospital through Partners Health CareOngoing
188 A  study  to assess TB treatment outcomes in the HIV/TB co-infected patients receiving care and compare rural and urban settings and also identify factors associated with TB treatment outcome.  European & Developing Countries Clinical Trials Partnership (EDCTP) / London School of Hygiene and tropical Medicine  Ongoing 
193Operational Research for Cryptococcal Antigen Screening of HIV PatientsNational Institutes of Health(NIH) / University of Minnesota Ongoing 
194Innovative incentive for sustainable HIV testing and linkage to care: The aim of this project is to stimulate HIV malignancy research via support of collaborative pilot projects in NCI-designated Cancer Centers (CC) and low and middle income countries (LMICs), per World Bank classification.National Institutes of Health(NIH) / University of California San FranciscoOngoing 
197CIPLA Trial Study: A multicenter, open label, randomized, multiple dose, two period crossover, steady state study to compare the bioequivalence of the Test product<Amphotericin B(Liposome for injection) 50mg/vial, Cipla Ltd., India> with that of the Reference product<AmBisome (Amphotericin B) Liposome for injection 50mg/vial), Gilead life sciences, USA> in adult patients with fungal infectionsCIPLA Ltd / Quintiles Clindepharm LtdOngoing 
199Early Stage Diagnosis of Kaposi’s Sarcoma in Limited Resource Settings using KS-Detect. National Institutes of Health(NIH) / University of California San Francisco Ongoing
201Nodding Syndrome; A trans-disciplinary approach to identify the cause and decrease the incidence of river epilepsy European Research Executive Agency /University of AntwerpOngoing 
202International Epidemiologic databases to Evaluate AIDS - East Africa (IeDEA). The International epidemiologic Database to Evaluate AIDS (IeDEA),   is a consortium of HIV care clinics and HIV research institutions in a specific region, that aims to collect, merge and analyze large HIV datasets. National Institutes of Health / The Trustee of Indiana UniversityOngoing
202BIeDEA Kaposis Sarcoma supplement grant: The objective of the study is to Collect Data that would be used in East Africa IeDEA & Global IeDEA studies designed to look at KS incidences & address outcomes of patients diagnosed with KS.National Institutes of Health / The Trustee of Indiana UniversityOngoing
203The Canadian African Prevention Trials Network (CAPT) PhD Training Scholarship. The project aims to study sexual Behavior and HIV transmission risk among Uganda patients who have been receiving ART for 8 years or more.The Canadian African Prevention Trials Network (CAPT) / University of Cape TownOngoing
204The Incidence and Predictors of Impaired Bone Healthy and Fragility in HIV Infected Patients on Long-Term HAART in Uganda:Bone Mineral density in HIV infected patients on long term ART in UgandaNational Institutes of Health(NIH) / University of AlabamaOngoing
206High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Randomised Controlled Non-inferiority Trial (AMBITION-cm). This project aims to examine whether short-course high-dose liposomal amphotericin B (AmBisome), given with high dose fluconazole, is non-inferior (in terms of microbiological and clinical endpoints) to standard-dose 14-day courses of AmBisome plus high dose fluconazole for treatment of HIV-associated Cryptococcal meningitis (CM) .European and Developing Countries Clinical Trials Partnership (EDCTP) / London School of Hygiene &Tropical Medicine (LSHTM)Ongoing

Outreach Projects

Project CodeProgram Name/DetailsPartners (Funder/Other Partners)Status
024Support for the project to build the capacity of Kampala Capital City Authority (KCCA) to scale up HIV prevention, care, treatment and support servicesUS Centers for Disease Control and Prevention/Mulago -Mbarara Teaching Hospitals' Joint AIDS Program (MJAP)Completed
053Building Capacity for Scaling up HIV/AIDS Services in Kibaale, Kiboga and 5 other districts of Western Uganda (EKKP)US Centers for Disease Control and Prevention (CDC)Completed
053BStrengthening HIV Test Access and Treatment Uptake StudyUS Centers for Disease Control and Prevention (CDC)Completed
077Expansion of Access to, coverage and utilization of HCT services in 22 districts in Uganda (REACH-U)United States Agency for International Development (USAID)/Mulago-Mbarara Teaching Hospitals’ Joint Program (MJAP)Completed
086Project to strengthen the capacity of Kampala Capital City Authority(KCCA) to provide comprehensive HIV/AIDS services for children and adults in KampalaUS Centers for Disease Control and Prevention (CDC)Ongoing
086BProject to strengthen the capacity of health units in Kampala Capital City Authority (KCCA) and selected districts of Uganda to scale up Voluntary Medical Male Circumcision(MMC)(AMAKA project)US Centers for Disease Control and Prevention (CDC)Ongoing
086CSaving Mother Giving Life Project (SMGL): The IDI site (Kibale district) of a multi-site project aimed at demonstrating significant reduction in maternal mortality as a result of a multi-faceted intervention in selected areas of Uganda and ZambiaUS Centers for Disease Control and Prevention (CDC)Ongoing
091Support to the Comprehensive Faith and Community based HIV/AIDS Prevention, Care and Treatment programmeUSAID/ Inter-Religious Council of Uganda (IRCU)Completed
103Building and maintaining the capacity of Community-Based Organizations to Contribute to the Prevention of Mother to Child Transmission of HIV in Kiboga and Kyankwanzi Districts, UgandaViiV Health CareCompleted
144Construction of Maternity In-Patient blocks in Kiboga & KyankwanziJapan International Cooperation Agency (JICA)/Embassy of Japan in UgandaCompleted
158The ELMA Foundation –Enhancing the New born Component of the Saving Mothers, Giving Life project in Kibaale District, UgandaThe ELMA foundationOngoing
172Accelerating Comprehensive HIV/AIDS Service Delivery through Health System Capacity Building and Technical Assistance to District Health Teams and Health Facilities in Western Regions of Uganda / Bunyoro HIV/AIDS Project(BHP).US Centers for Disease Control and Prevention (CDC)Ongoing
174Kyaterekera maternity ward Construction , The aim of this project is to improve Health facility infrastructure through expanding maternity ward in order to ease congestion, create additional space for beds for expectant mothers from the present 13 to 24.Mehdi Attarha & Emily Hill, Carla Duarte, Alison & Alex PittOngoing
190AClosing the Paediatric-Adult Treatment Gap in Uganda: A project to improve early diagnosis of children and adolescents with HIV by increasing testing, screening, case finding and linkages to treatment and support.ELMA Foundation (Co-funding)Ongoing
190BClosing the Paediatric-Adult Treatment Gap in Uganda: A project to improve early diagnosis of children and adolescents with HIV by increasing testing, screening, case finding and linkages to treatment and support.Elton John AIDS Foundation (Co-funding)Ongoing

Systems Strengthening Projects

Project CodeProgram Name/DetailsPartners (Funder/Other Partners)Status
001Unrestricted support to IDI to mantain the "costs of excellence"Pfizer Inc./Pangaea Global AIDS Foundation/ Accordia Global Health FoundationCompleted
002HSupport to complete the Kasangati HC-HIV Prevention Center of ExcellenceHellman Foundation/Bill and Melinda Gates Foundation/University of Washington/ Accordia Global Health FoundationCompleted
027Partnership between the AIDS Treatment Information Centre (ATIC) and the AIDS Resource Centre (ARC) in Ethiopia to improve the quality of HIV care and treatment services provided by clinicians in EthiopiaUS Department of Health and Human Services’ Health Resources and Services Administration (HRSA))/American International Health Alliance (AIHA)Completed
035Global Fund Round 3 (Phase 1) support for critical HIV/AIDS activities at IDI: (1) ART training ; (2) Lab training (final); (3) Special Operations Research studies; (4) Lab Quality Assurance for HIV/AIDSGlobal Fund to fight AIDS, Tuberculosis and Malaria/ AIDS Control Programme, Ministry of Health, UgandaCompleted
050Support to the Strengthening Pharmaceutical Systems (SPS) projectUSAID / Management Science for Health, IncCompleted
051Pfizer Global Health Fellows ProgramPfizer Inc./Accordia Global Health FoundationCompleted
058Support for development of the proposed West Africa Infectious Diseases Institute (WAIDI)Accordia Global Health FoundationCompleted
069Support to the "Partnership for building the capacity of Makerere University to improve priority health outcomes in Uganda"Bill and Melinda Gates Foundation / Johns Hopkins University / Makerere UniversityCompleted
070Support to the Makerere University-Johns Hopkins University (MUJHU)Collaboration project : “Development of Sustainable HIV Clinical Trials Research Capacity in Uganda” (an NIH Planning grant)National Institutes of Health (NIH)/Makerere University-John Hopkins University Research Collaboration (MUJHU)Completed
075Administrative support to the Makerere University-University of Medicine and Dentistry of New JerseyUniversity of Medicine and Dentistry of New Jersey -NJMSCompleted
081ASupport to the Epidemiology of Burkitt Lymphoma in East Africa Children and minors ( EMBLEM) -procument services.National Cancer Institute through WESTATOngoing
081BSupport to the Epidemiology of Burkitt Lymphoma in East Africa Children and minors ( EMBLEM)-Datafax supportNational Cancer Institute through Information Management Services (INC).Completed
085Provision of skills in specified areas through Ugandan/American pairs of global health fellows attached to IDIGlobal Health Corps Program (GHC)Completed (annual renewals)
094Application of the Capacity Pyramid in NepalBill and Melinda Gates FoundationCompleted
096Support to IDI and Kampala Capital City Authority Outreach Clinics (KCCA) patients' resource centersMr. Scott Spector/Accordia Global Health FoundationCompleted
106Construction of a Center of Excellence for HIV Prevention at the Infectious Diseases InstituteWillow Springs/Accordia Global Health FoundationCompleted
120IDI's emergency response to the Ebola outbreak in Kibaale District of Uganda (2012)Pfizer Inc/Merck&Co./Accordia Global Health FoundationCompleted
122Project to carry out Pharmacology Laboratory Renovations in the School of Biomedical Sciences, College of Health Sciences, Makerere UniversityUniversity of California San Francisco (UCSF) /National Institutes of Health (NIH)Completed
125Support to the Strengthening Decentralization for Sustainability (SDS) program; provision of Technical Assistance in Grants Management, Management Information Systems (MIS) and Monitoring and Evaluation (M&E) to local governments in 35 USAID supported Districts in Uganda.USAID/Cardno Emerging MarketsOngoing
127BAfya Bora Consortium FellowshipUniversity of Washington/Afya Bora Consortium Fellowship.Ongoing (annual renewals)
127Nurse Education Program-Funds to support Brenda Mitchell’s volunteer work with the Nurse Education Program at IDI.Brenda Mitchell/Pfizer’s VOLUNTEERS challenge.Completed
129Technical Assistance to CAF -CDC on Roles and responsibilities related to provision of comprehensive treatment, care and prevention services at the seven (7) indigenous health facilities in several districts across the country.Centers for Disease Control (CDC)/Childrens' AIDS Fund (CAF)Completed
139Provision Of HIV/AIDS And TB Related Laboratory Support and Technical Assistance (TA) Services to the Ministry of Health (MOH) of the Kingdom Of Swaziland under PEPFAR (Phases I, II and III)US Centres For Disease Control and Prevention (CDC) / University Research Council (URC), Swaziland.Completed
152Improving Child Nutrition in Urban slums of Uganda. IDI acts as a Fiscal agent.Grand Challenges Canada to Global Health Economics (IDI is a fiscal agent).Completed
153Development of Mobile phone gaming application to increase knowledge of HIV/AIDS prevention.Grand Challenges Canada to Global Health Economics (IDI is a fiscal agent).Completed
154Using routine immunization to increase access to Cervical Cancer Screening in rural Uganda.Grand Challenges Canada to Global Health Economics (IDI is a fiscal agent).Completed
166Subcontract to support CH2MHILL Inc in execution of the US DTRA Contract for Uganda Biosafety and Biosecurity (BS&S) Laboratory Upgrades.Defense Threat Reduction Agency (DTRA)/CH2MHILL Inc, USA.Completed
198East Central and Southern Africa College of Physicians (ECSACOP):To improve standards of healthcare throughout the region by providing specialist training for physicians committed to lifelong learning.Royal College of Physicians (RCP)Ongoing

For more details regarding IDI projects and funders please email the IDI Grants and Contracts Office at This email address is being protected from spambots. You need JavaScript enabled to view it. .

(Updated 20 April 2016)